Manual analysis of the literature indicates that NKX3.1, PTEN and CDKN1B are important oncosuppressors that are lost upon deletion of the 3 loci9, 10, 11, 12, 13 and are known to play a driver role in prostate cancer evolution. This evidence concerns the gene PTEN and prostate carcinoma.